The evolution towards innovative drugs, like biologics or cell & gene, is marking a turning point in the clinical trial landscape. The clinical supply chain is not a support group anymore, but an active driver of the success and speed of a clinical trial.
Bottlenecks or delays in drug supply are one of the causes of delays in trial timelines and a major factor in even considering a trial feasible. As the next 10 years will worsen this issue, pharmaceutical companies will have to ensure best-in-class drug waste management to stay competitive.
Elementum pulvinar etiam non quam. Pellentesque diam volutpat commodo sed egestas egestas fringilla phasellus. Nisi lacus sed viverra tellus in hac habitasse. Semper auctor neque vitae tempus. Auctor eu augue ut lectus arcu. Massa ultricies mi quis hendrerit dolor magna eget est lorem. Arcu bibendum at varius vel pharetra vel turpis nunc. Dolor sit amet, consectetur adipiscing elit, sed do eiusmod. Ullamcorper malesuada proin libero nunc. Felis eget velit aliquet sagittis id consectetur purus. Ipsum dolor sit amet consectetur adipiscing elit.
Consectetur purus ut faucibus pulvinar elementum integer. Accumsan sit amet nulla facilisi. Sed felis eget velit aliquet sagittis. Volutpat odio facilisis mauris sit amet massa vitae. Amet consectetur adipiscing elit ut aliquam purus sit amet luctus.
Amaury Jeandrain is an expert in clinical trial supply and manufacturing optimization. He started his career in clinical supply chain working for a CMO before joining N-SIDE. In his 6 years of experience at N-SIDE, Amaury supported the optimization of hundreds of trials and programs from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of experts focusing on bringing knowledge about optimization to the industry.
Alexis Davin is a clinical optimization specialist at N-SIDE and a volunteer at the GCSG. His experience in clinical supply expanded quickly by solving day-to-day supply challenges of biopharma companies. He is passionate about how digitalization can improve the clinical supply industry and, ultimately, impact patients’ health. Alexis is also supporting the development of new digital solutions to solve supply chain issues in clinical trials, which offers him a strategic view on industry trends and internal processes.